An immune-cell therapy shrank children's brain tumors, restored neurologic function and—for one participant in a Stanford ...
In the world of cell therapy, Silicon Valley has long recognized that technological innovation is the key to solving ...
News Medical on MSN1h
CAR T cell therapy breakthroughs bring new hope for treating solid tumorsScientists push CAR T cell therapy beyond blood cancers, unlocking potential for targeting solid tumors with enhanced ...
The pharmaceutical distributor has launched InspiroGene, a business unit offering logistics and other support for ...
An expert explained how a patient’s own T cells can be extracted, manufactured and infused back into the body as a treatment ...
With more than $80 million in hand, the University of Texas MD Anderson Cancer Center has launched its own cell therapy ...
The in vivo cell therapy seed Carisma Therapeutics planted with Moderna in 2022 is starting to sprout. | The in vivo cell ...
MedPage Today on MSN6d
Overcoming the Challenges of Applying CAR T-Cell Therapy to Solid TumorsOpens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window ...
Glioblastoma is the most common kind of malignant brain tumor in adults. So far, no treatment has been able to make this ...
News Medical on MSN5d
MD Anderson launches new institute for advancing cell therapyThe University of Texas MD Anderson Cancer Center today announced the launch of its Institute for Cell Therapy Discovery & Innovation, which will build upon longstanding MD Anderson clinical and ...
A patient with sickle cell disease died while participating in a clinical trial of a CRISPR-based treatment from Beam Therapeutics, threatening to overshadow early signals of effective gene editing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback